<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38746446</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Apr</Month><Day>29</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Crystallographic Fragment Screen of Coxsackievirus A16 2A Protease identifies new opportunities for the development of broad-spectrum anti-enterovirals.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.04.29.591684</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.04.29.591684</ELocationID><Abstract><AbstractText><i>Enteroviruses</i> are the causative agents of paediatric hand-foot-and-mouth disease, and a target for pandemic preparedness due to the risk of higher order complications in a large-scale outbreak. The 2A protease of these viruses is responsible for the self-cleavage of the poly protein, allowing for correct folding and assembly of capsid proteins in the final stages of viral replication. These 2A proteases are highly conserved between <i>Enterovirus</i> species, such as <i>Enterovirus A71 and Coxsackievirus A16</i> . Inhibition of the 2A protease deranges capsid folding and assembly, preventing formation of mature virions in host cells and making the protease a valuable target for antiviral activity. Herein, we describe a crystallographic fragment screening campaign that identified 75 fragments which bind to the 2A protease including 38 unique compounds shown to bind within the active site. These fragments reveal a path for the development of non-peptidomimetic inhibitors of the 2A protease with broad-spectrum anti-enteroviral activity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lithgo</LastName><ForeName>Ryan M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0002-4706-9916</Identifier></Author><Author ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>Charles W E</ForeName><Initials>CWE</Initials><Identifier Source="ORCID">0000-0002-1845-6028</Identifier></Author><Author ValidYN="Y"><LastName>Fairhead</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5361-3933</Identifier></Author><Author ValidYN="Y"><LastName>Winokan</LastName><ForeName>Max</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Warren</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-1474-7810</Identifier></Author><Author ValidYN="Y"><LastName>Wild</LastName><ForeName>Conor</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0654-8141</Identifier></Author><Author ValidYN="Y"><LastName>Aschenbrenner</LastName><ForeName>Jasmin Cara</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-4318-0481</Identifier></Author><Author ValidYN="Y"><LastName>Balcomb</LastName><ForeName>Blake H</ForeName><Initials>BH</Initials><Identifier Source="ORCID">0000-0001-7599-8467</Identifier></Author><Author ValidYN="Y"><LastName>Marples</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials><Identifier Source="ORCID">0000-0002-8787-7969</Identifier></Author><Author ValidYN="Y"><LastName>Chandran</LastName><ForeName>Anu V</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0001-9942-2614</Identifier></Author><Author ValidYN="Y"><LastName>Golding</LastName><ForeName>Mathew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0004-7472-8333</Identifier></Author><Author ValidYN="Y"><LastName>Koekemoer</LastName><ForeName>Lizbe</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9226-9127</Identifier></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Eleanor P</ForeName><Initials>EP</Initials><Identifier Source="ORCID">0000-0002-1331-9518</Identifier></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>SiYl</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Xiaomin</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-7769-8297</Identifier></Author><Author ValidYN="Y"><LastName>MacLean</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1680-4292</Identifier></Author><Author ValidYN="Y"><LastName>Giroud</LastName><ForeName>Charline</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1629-1581</Identifier></Author><Author ValidYN="Y"><LastName>Godoy</LastName><ForeName>Andre Schutzer</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-0613-9164</Identifier></Author><Author ValidYN="Y"><LastName>Xavier</LastName><ForeName>Mary-Ann</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-1709-9479</Identifier></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5683-1151</Identifier></Author><Author ValidYN="Y"><LastName>Fearon</LastName><ForeName>Daren</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3529-7863</Identifier></Author><Author ValidYN="Y"><LastName>von Delft</LastName><ForeName>Frank</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0378-0017</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38746446</ArticleId><ArticleId IdType="pmc">PMC11092469</ArticleId><ArticleId IdType="doi">10.1101/2024.04.29.591684</ArticleId><ArticleId IdType="pii">2024.04.29.591684</ArticleId></ArticleIdList></PubmedData></PubmedArticle>